Outset Medical, Inc.
OM
$15.04
-$1.02-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.75M | 29.47M | 28.67M | 27.39M | 28.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.75M | 29.47M | 28.67M | 27.39M | 28.17M |
| Cost of Revenue | 18.69M | 18.14M | 18.85M | 17.61M | 19.65M |
| Gross Profit | 11.07M | 11.33M | 9.82M | 9.78M | 8.52M |
| SG&A Expenses | 21.99M | 21.85M | 25.52M | 30.81M | 31.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.16M | 45.77M | 52.51M | 58.15M | 62.12M |
| Operating Income | -16.41M | -16.31M | -23.84M | -30.76M | -33.96M |
| Income Before Tax | -25.67M | -25.64M | -27.76M | -34.30M | -39.78M |
| Income Tax Expenses | 115.00K | -4.00K | 182.00K | 151.00K | 162.00K |
| Earnings from Continuing Operations | -25.78M | -25.64M | -27.94M | -34.45M | -39.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.78M | -25.64M | -27.94M | -34.45M | -39.94M |
| EBIT | -16.41M | -16.31M | -23.84M | -30.76M | -33.96M |
| EBITDA | -15.11M | -14.90M | -22.45M | -29.29M | -32.50M |
| EPS Basic | -3.66 | -7.29 | -8.30 | -9.96 | -11.77 |
| Normalized Basic EPS | -1.60 | -3.57 | -5.15 | -6.20 | -6.78 |
| EPS Diluted | -3.66 | -7.29 | -8.30 | -9.96 | -11.77 |
| Normalized Diluted EPS | -1.60 | -3.57 | -5.15 | -6.20 | -6.78 |
| Average Basic Shares Outstanding | 7.04M | 3.52M | 3.37M | 3.46M | 3.39M |
| Average Diluted Shares Outstanding | 7.04M | 3.52M | 3.37M | 3.46M | 3.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |